[(2S,3S,4S,5R,6S)-6-bromo-3,4,5-tris(2,2-dimethylpropanoyloxy)tetrahydropyran-2-yl]methyl

[(2S,3S,4S,5R,6S)-6-bromo-3,4,5-tris(2,2-dimethylpropanoyloxy)tetrahydropyran-2-yl]methyl

81058-27-7

C₂₆H₄₃BrO₉

MFCD08275217

2,3,4,6-tetra-o-pivaloyl-a-d-glucopyranosylbromide ; 4. 2,3,4,6-tetra-o-pivaloyl-alpha-d-glucopyranosyl bromide ; canagliflozin intermediate3 ; 2,3,4,6-tetra-o-pivaloyl-a-d-glucopyranosyl bromide (stabilised with caco3) ; tetrakis(2,2-dimethylpropanoate)-a-d-glucopyranosyl bromide ; 2,3,4,6-tetra-o-pivaloyl-alpha-d-glucopyranosyl bromide >=90% (tlc) ; tetra-o-pivaloyl-alpha-d-glucopyranosyl bromide ; per-o-pivaloyl-±-d-glucopyranosyl bromide ; α-d-glucopyranosyl bromide, 2,3,4,6-tetra-o-pivaloyl ; 2,3,4,6-tetra-o-pivaloyl-alpha-d-glucopyranosyl bromide